Skip to main content

Propel Bio Management, LLC

Source: SEC Form 13F · as of Mar 2026

Propel Bio Management, LLC holds 28 biotech & pharma companies tracked by BioSniper, totaling $84.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

28

Total value held

$84.9M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Phathom Pharmaceuticals, Inc. (PHAT)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
PHATPhathom Pharmaceuticals, Inc.841,272$9.4M
CORTCORCEPT THERAPEUTICS INC147,828$6.0M
VORVor Biopharma Inc.314,543$5.6M
KYTXKyverna Therapeutics, Inc.644,421$5.6M
CLDXCelldex Therapeutics, Inc.131,364$4.1M
CMPSCOMPASS Pathways plc742,049$4.1M
VRDNViridian Therapeutics, Inc.\DE210,163$4.1M
IVAInventiva S.A.724,678$4.0M
SABSSAB BIOTHERAPEUTICS, INC.1,012,790$3.9M
FDMT4D Molecular Therapeutics, Inc.380,420$3.6M
OCSOculis Holding AG122,223$3.3M
OCULOCULAR THERAPEUTIX, INC382,375$3.2M
UPBUpstream Bio, Inc.341,779$3.1M
AQSTAquestive Therapeutics, Inc.710,988$3.0M
TRVITrevi Therapeutics, Inc.223,802$2.6M
ZVRAZEVRA THERAPEUTICS, INC.282,418$2.6M
CHRSCoherus Oncology, Inc.1,420,550$2.4M
OVIDOvid Therapeutics Inc.921,457$2.0M
PALIPALISADE BIO, INC.1,115,000$2.0M
QUREuniQure N.V.104,772$1.7M
LONALeonaBio, Inc.149,279$1.5M
NUVBNuvation Bio Inc.329,296$1.4M
MAZEMaze Therapeutics, Inc.43,798$1.3M
EVMNEvommune, Inc.55,664$1.3M
CRVSCorvus Pharmaceuticals, Inc.85,791$1.3M
ALDXAldeyra Therapeutics, Inc.730,606$1.2M
CNTBConnect Biopharma Holdings Ltd209,493$554K
MSLESatellos Bioscience Inc.10,145$57K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.